Safety and Immunogenicity Study of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Infants
Reactogenicity and Immunogenicity of Live Attenuated Indian Rotavirus Vaccine Candidate Strains 116E and I321 in Healthy Non-Malnourished Infants 8-12 Weeks of Age
Sponsor: All India Institute of Medical Sciences
A PHASE1 clinical study on Rotavirus Infections, this trial is completed. The trial is conducted by All India Institute of Medical Sciences and has accumulated 6 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.
Status Flow
Change History
6 versions recorded-
Jul 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Jul 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE1
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE1
▶ Show 1 earlier version
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE1
First recorded
Jan 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- All India Institute of Medical Sciences
- Centers for Disease Control and Prevention
- Children's Hospital Medical Center, Cincinnati
- Indian Institute of Science
- Ministry of Science and Technology, India
- National Institutes of Health (NIH)
- PATH
- Society for Applied Studies
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .